Lung metastasis following temporary discontinuation of lenvatinib and tislelizumab in hepatocellular carcinoma: A case report

• Published in: World journal of gastrointestinal surgery Vol. 17; no. 3; p. 100951
• Main Authors: Wang, Chen-Dong, Liu, Run-Dong, Liu, Ming-Jie, Song, Jia
• Format: Journal Article
• Language: English
• Published: United States Baishideng Publishing Group Inc 27.03.2025
• Subjects: Case Report; Conversion therapy; Hepatocellular carcinoma; Tislelizumab; Case report; Lenvatinib; Hepatic arterial infusion chemotherapy

BACKGROUND Hepatocellular carcinoma (HCC) is a prevalent malignancy in China, primarily diagnosed at advanced stages, which limits treatment options and increases mortality rates. Conversion therapy, which includes systemic and locoregional treatments, aims to render unresectable tumors resectable....